Fairfield Financial Advisors, LTD

Position in JNJ — Johnson & Johnson

CIK 2033232 WELLESLEY, MA

Position in JNJ

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$396,701

+$355,485 QoQ

Shares Held

1,562

+448.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#3,923

of 4,664 holders

Holding Since

Mar 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fairfield Financial Advisors, LTD holds $15,764,978 across 4 Drug Manufacturers - General names. JNJ ranks #3 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	11,166	$13,392,836
2	AMGN	Amgen Inc	4,758	$1,722,966
3	JNJ	Johnson & Johnson This page	1,562	$396,701
4	NVS	Novartis AG	1,611	$252,475

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$396,701	1,562	+448.1%	Shares	Sole	2026-08-11
2024-12-31	$41,216	285	0.0%	Shares	Sole	2025-02-07
2024-09-30	$46,187	285	-8.9%	Shares	Sole	2024-10-28
2024-06-30	$45,748	313	-72.8%	Shares	Sole	2024-08-09
2023-12-31	$180,407	1,151	-41.8%	Shares	Sole	2024-11-04
2023-09-30	$308,073	1,978	-25.7%	Shares	Sole	2024-11-04
2023-06-30	$440,448	2,661	-7.0%	Shares	Sole	2024-11-04
2023-03-31	$443,300	2,860	+66.4%	Shares	Sole	2024-11-04
2022-12-31	$303,661	1,719	+4.6%	Shares	Sole	2024-10-07
2022-09-30	$268,400	1,643	+0.2%	Shares	Sole	2024-10-07
2022-06-30	$290,938	1,639	-18.2%	Shares	Sole	2024-10-07
2022-03-31	$355,168	2,004	—	Shares	Sole	2024-10-07
No filing history on record for this holder in this stock.